Skip to content
MedsAcross

Brand family

Xadago

Safinamide · MDD US Operations
United States
Presentations
2
Markets
1

Xadago is a brand of Safinamide marketed by MDD US Operations, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Safinamide
Brand owner
MDD US Operations
Registered in
United States
Strengths and forms
100 mg tablet, 50 mg tablet

All presentations

MedicineManufacturerRegisterAvailability
Xadago 100 mg tabletOralMDD US OperationsUS FDAAvailable on request
Xadago 50 mg tabletOralMDD US OperationsUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Xadago

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.